Filip De Vos

9.5k total citations
281 papers, 5.0k citations indexed

About

Filip De Vos is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Genetics. According to data from OpenAlex, Filip De Vos has authored 281 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Radiology, Nuclear Medicine and Imaging, 76 papers in Oncology and 61 papers in Genetics. Recurrent topics in Filip De Vos's work include Glioma Diagnosis and Treatment (58 papers), Radiopharmaceutical Chemistry and Applications (43 papers) and Medical Imaging Techniques and Applications (29 papers). Filip De Vos is often cited by papers focused on Glioma Diagnosis and Treatment (58 papers), Radiopharmaceutical Chemistry and Applications (43 papers) and Medical Imaging Techniques and Applications (29 papers). Filip De Vos collaborates with scholars based in Belgium, Netherlands and United States. Filip De Vos's co-authors include Guido Slegers, Bieke Lambert, Ingeborg Goethals, Christian Vanhove, Tom J. Snijders, Ken Kersemans, Stefaan C. De Smedt, Jo Demeester, Elisabeth G.E. de Vries and Jan Versijpt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Filip De Vos

261 papers receiving 4.9k citations

Peers

Filip De Vos
Comparison fields: 5 of 157
  • Molecular Biology 1.2k
  • Radiology, Nuclear Medicine and Imaging 1.1k
  • Oncology 1.0k
  • Pulmonary and Respiratory Medicine 1.0k
  • Genetics 734
Replace Akiva Mintz with:
Akiva Mintz United States
Sohita Dhillon New Zealand
Mitch A. Phelps United States
Leslie L. Muldoon United States
Takamasa Kayama Japan
Daohai Yu United States
Jaetae Lee South Korea
George Α. Alexiou Greece
Mika Watanabe Japan
Terence S. Herman United States
Akiva Mintz United States View profile →
Citations per field, relative to Filip De Vos
Filip De Vos · 1×
Citations per year, relative to Filip De Vos
Filip De Vos · 1×

Countries citing papers authored by Filip De Vos

Since Specialization
Citations

This map shows the geographic impact of Filip De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip De Vos more than expected).

Fields of papers citing papers by Filip De Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip De Vos. The network helps show where Filip De Vos may publish in the future.

Co-authorship network of co-authors of Filip De Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Filip De Vos. A scholar is included among the top collaborators of Filip De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip De Vos. Filip De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 0
4 2
5 3
6 1
7 7
8 6
9 24
10 34
11 13
12 43
13
Using Tc-99m-HMPAO SPECT as tool to compare two Transcranial Magnetic Stimulation protocols and their long-term effects in dogs
1
14 15
15
F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study
1
16
Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients
1
17
Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis
2
18 14
19
Re-188-HDD/Lipiodol for hepatocellular carcinoma: our experience with the first 100 treatments.
1
20
High-performance liquid chromatography of (11C(1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide in mice plasma and tissue and in human plasma.
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026